Robert K.
Woo, Jr.
(Bobby)

Defended a major pharmaceutical company facing more than 600 cases alleging that maternal use of a prescription medication caused congenital malformations; lead attorney in case management and special master hearings in the Mass Tort Program (MTP) in Philadelphia, where the bulk of these cases are pending.

Drafted amicus brief to the Supreme Court of Georgia on behalf of the four largest Asian-Pacific American civil rights groups in the country regarding the use of court interpreters for criminal defendants during plea bargain negotiations; resulted in conviction being vacated and case remanded for re-trial.

Defended a major pharmaceutical company involved in more than 1,300 individual and class action suits, filed in more than 32 states, alleging failure to warn and overly-aggressive marketing of a prescription medication; part of a team that defeated class certification in numerous courts and obtained 410 dismissals, including 27 orders granting summary judgment.

Led a team of attorneys on two asylum cases on behalf of a pair of Ivory Coast citizens who had suffered persecution on account of their political activities, pursuing the matter through trial (merits hearing) and an appeal before the Board of Immigration Appeals.

Defended a major manufacturer of consumer goods and medical products in dozens of product liability cases involving silicone breast implants.

Authored chapter on "Expert Testimony, Rule 702, and Daubert" in Drug and Device Product Liability Litigation Strategy (2d. ed. 2016).

Co-authored chapter on "Attorney-Client Privilege" in the treatise Regulation of Pharmaceutical Manufacturers (2012).

Authored “Managing the Real Estate Investment Trust: An Alternative to the Independent Contractor Requirement,” 107 Harvard Law Review 1117 (1994), reprinted in The Monthly Digest of Tax Articles (February 1995).

Bobby has appeared on panels addressing issues such as the attorney-client privilege, expert witnesses and scientific evidence, diversity, professionalism, and civil procedure; for the last seven years, has been responsible for training the firm’s new attorneys on efficient legal research techniques.